Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet

International Journal of Obesity

Volumn 34, Issue 8, 2010, Pages 1341-1344

  Gault, V A ^a   Porter, W D ^a   Flatt, P R ^a   Holscher C ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

diet induced obesity; exendin 4; GLP 1; object recognition; synaptic plasticity

Indexed keywords

EXENDIN 4; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HIPPOCAMPUS; IN VIVO STUDY; LEARNING; LIPID DIET; MALE; MEMORY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ANIMALS; COGNITION DISORDERS; DIETARY FATS; HIPPOCAMPUS; MALE; MICE; NEURONAL PLASTICITY; PEPTIDES; VENOMS;

MUS; RODENTIA;

EID: 77955470617     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.59     Document Type: Article

References (13)

1. Lovshin JA, Drucker DJ. Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 2009; 5: 262-269.
2. Hamilton A, Hölscher C. Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system. Neuroreport 2009; 20: 1161-1166.
3. During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 2003; 9: 1173-1179.
4. Abbas T, Faivre E, Hölscher C. Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease. Behav Brain Res 2009; 205: 265-271.
5. Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, Egan JM et al. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron. J Neurosci Res 2003; 72: 603-612.
6. Gault VA, Hölscher C. GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. Eur J Pharmacol 2008; 587: 112-117.
7. Kastin AJ, Akerstrom V, Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci 2002; 18: 7-14.
8. Stranahan AM, Normal ED, Lee K, Cutler RG, Telljohann RS, Egan JM et al. Diet-induced insulin resistance impairs hippocam-pal synaptic plasticity and cognition in middle-aged rats. Hippocampus 2008; 18: 1085-1088.
9. Flatt PR, Bailey CJ. Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia 1981; 20: 573-577.
10. Trudeau F, Gagnon S, Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol 2004; 490: 177-186.
11. Hansotia T, Maida A, Flock G, Yamada Y, Tsukiyama K, Seino Y et al. Extrapancreatic incretin receptors modulate glucose homeostasis, body weight and energy expenditure. J Clin Invest 2007; 117: 143-152.
12. McGovern SF, McClean P, Gault VA, Holscher C. Novel GLP-1 Analogues Improve Memory FormationFA Link Between Diabetes and Alzheimer's Disease. Neuroscience Annual Meeting; 2009; Society for Neuroscience: Chicago, IL, Abstract 529.7.
13. Zachrisson O, Isacson R, Nielsen E, Bertilsson G, Dannaeus K, Wikstrom LB. Exendin-4 Stimulates Hippocampal Neurogenesis and Exerts Affective and Cognition Associated Effects in Behavioral Models. Neuroscience Annual Meeting; 2009; Society for Neuroscience: Chicago, IL, Abstract 549.4.